Behandling af homozygot familiær hypercholesterolæmi som et supplement til diæt og andre lipidsænkende behandlinger (f. eks.
After an assessment of the documentation provided by the MAH and an evaluation of the current EU- wide clinical practices relating to the use of Zocord the following was considered to be the most suitable harmonised Section 4.2 Posology text: